Search

BIOHIT HealthCare is exhibiting at the BSI congress 2022

BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.

Wraparound IBD care pathway for enhanced patient outcomes

BIOHIT HealthCare is pleased to announce its partnership with Celltrion Healthcare UK Ltd, providing point-of-care assays for the Celltrion Connect Dedicated Homecare Service, which is designed to seamlessly support patients with inflammatory bowel disease (IBD) and their healthcare providers.

BIOHIT launches new quick test to help streamline gastroscopy referrals

BIOHIT HealthCare Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer.

MedTech Company KARL STORZ Acquires British AI Specialist Innersight Labs

The family-owned MedTech company KARL STORZ announces the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London.

Innovative Digital Operating Theatres from KARL STORZ

A major project with the Hospital Alemán in Buenos Aires, Argentina, shows that KARL STORZ's complete solutions for operating theaters, known as OR1™, enjoy a great reputation worldwide.

KARL STORZ Gains Approval for Solo+™ Revolutionary Ear Tube Placement Device

Chronic ear infections are a leading reason for doctor visits and surgical procedures such as placement of ear tubes in young children.

Oticon Medical announces (FDA) clearance and CE mark of its first active transcutaneous bone conduction hearing system, the Sentio™ System.

The Sentio System delivers the proven benefits of the Ponto™ System – and more – in a transcutaneous option.

Neuromod closes €10 million financing to accelerate commercialisation

Neuromod, an Irish medical device company specialising in tinnitus, has closed a €10 million equity financing deal in a Series B fundraising expansion to expand the availability of tinnitus treatment device, Lenire. Financing was oversubscribed and led by existing investors...

Oticon Medical Hosts Fifth Annual Good Vibrations Day

April 22, 2025. Gothenburg, Sweden. Oticon Medical is thrilled to announce the fifth annual Good Vibrations Day campaign, a month-long initiative dedicated to raising awareness about bone anchored hearing. Beginning 3rd April 2025, this campaign has been featuring various social...

Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device

Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...